home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

4.710 -0.160 (-3.29%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

30 31 Next >

Psychedelic Stock Gainers And Losers From August 16, 2022 ↗

August 16, 2022

Via Benzinga

Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report ↗

August 15, 2022

Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility...

Via Benzinga

Allied, Cybin Among Top Psychedelic Movers Of Today ↗

August 15, 2022

Via Benzinga

Recap: ATAI Life Sciences Q2 Earnings ↗

August 15, 2022

ATAI Life Sciences (NASDAQ:ATAI) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Major Psychedelic Stocks Down This Week; Still Up Since End Of June ↗

August 14, 2022

The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then.

Via Talk Markets

Earnings Scheduled For August 15, 2022 ↗

August 15, 2022

Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

Via Benzinga

Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today ↗

August 12, 2022

Via Benzinga

ATAI Life Sciences Earnings: A Preview ↗

August 12, 2022

ATAI Life Sciences (NASDAQ:ATAI) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement.

Via Benzinga

Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

August 11, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From August 10, 2022 ↗

August 10, 2022

Via Benzinga

Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression

August 10, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study...

Via FinancialNewsMedia

Topics Supply Chain

Cybin, Field Trip Health Among Top Psychedelic Movers Of Today ↗

August 09, 2022

Via Benzinga

GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

August 05, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80

Via Benzinga

Psychedelic Stock Gainers And Losers From August 4, 2022 ↗

August 04, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17

Via Benzinga

Cathie Wood Continues Investing In Psychedelics, She Bought Over 3M Atai Shares In July Alone ↗

August 03, 2022

Several weeks ago, Cathie Wood's ARK Fund (BATS: ARKG) invested in the biotech psychedelics sector, specifically in major player

Via Benzinga

ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today ↗

August 02, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82

Via Benzinga

ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗

August 01, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34

Via Benzinga

July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD ↗

July 30, 2022

Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more.

Via Talk Markets

Psychedelic Stock Gainers And Losers From July 29, 2022 ↗

July 29, 2022

GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22

Via Benzinga

InvestorNewsBreaks – Atai Life Sciences (NASDAQ: ATAI) Featured in Analysis Report

July 29, 2022

Via Investor Brand Network

Topics Derivatives

Allied, Cybin Among Top Psychedelic Movers Of Today ↗

July 28, 2022

GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55

Via Benzinga

Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗

July 27, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06

Via Benzinga

Allied, GH Research Among Top Psychedelic Movers Of Today ↗

July 26, 2022

GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55

Via Benzinga

Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders

July 27, 2022

Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...

Via FinancialNewsMedia

Topics Law Enforcement

Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

July 25, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 2.76% at $14.91 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From July 22, 2022 ↗

July 22, 2022

GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50

Via Benzinga

Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

July 21, 2022

GAINERS: LOSERS: Allied (OTC:ALID) shares closed down 10.00% at $0.45

Via Benzinga

Dear Psychedelic Stocks Fans, Watch This Key Catalyst ↗

July 21, 2022

Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support.

Via InvestorPlace

Psychedelic Stock Gainers And Losers From July 20, 2022 ↗

July 20, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 10.53% at $15.11

Via Benzinga

Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

July 19, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 8.09% at $0.93

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com